[
    [
        {
            "time": "2023-10-25",
            "original_text": "Goldman Sachs: 3 High-Yield Dividend Stocks With Growth on the Horizon",
            "features": {
                "keywords": [
                    "Goldman Sachs",
                    "High-Yield",
                    "Dividend Stocks",
                    "Growth"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "finance"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "Goldman Sachs: 3 High-Yield Dividend Stocks With Growth on the Horizon",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 5,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 7,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        },
        {
            "time": "2023-10-25",
            "original_text": "Biogen (BIIB) Beats on Q3 Earnings, Eyes FDA Nod for Aducanumab",
            "features": {
                "keywords": [
                    "Biogen",
                    "Q3 Earnings",
                    "FDA",
                    "Aducanumab"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Biogen (BIIB) Beats on Q3 Earnings, Eyes FDA Nod for Aducanumab",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-10-25",
            "original_text": "How to identify U.S. stocks with attractive growth potential",
            "features": {
                "keywords": [
                    "U.S. stocks",
                    "growth potential"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "general"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "How to identify U.S. stocks with attractive growth potential",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 4,
                "Impact": 4,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 5,
                "Headline_Structure": 6,
                "Source_Recency": 5
            }
        }
    ]
]